Raymond James Starts WAVE Life Sciences (WVE) at Outperform, 'we expect WVE-006 (in AATD) and WVE-N531 (in DMD) to work and drive upside'
Tweet Send to a Friend
(Updated - July 5, 2023 6:53 AM EDT)
Raymond James analyst Steven Seedhouse initiates coverage on WAVE Life Sciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse initiates coverage on WAVE Life Sciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
